Attached files
| file | filename |
|---|---|
| 10-K/A - ANNUAL REPORT - SOLIGENIX, INC. | f10k2012a1_soligenix.htm |
| EX-32.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER - SOLIGENIX, INC. | f10k2012a1ex32i_soligenix.htm |
| EX-31.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER - SOLIGENIX, INC. | f10k2012a1ex31ii_soligenix.htm |
| EX-32.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER - SOLIGENIX, INC. | f10k2012a1ex32ii_soligenix.htm |
| EX-31.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER - SOLIGENIX, INC. | f10k2012a1ex31i_soligenix.htm |
EXHIBIT 21.1
SUBSIDIARIES OF SOLIGENIX, INC.
The following represents a list of Soligenix, Inc.’s subsidiaries:
|
Name
|
Ownership
|
State of
Incorporation
|
||||
|
Enteron Pharmaceuticals, Inc.
|
100.00
|
%
|
Delaware
|
|||
|
Orasomal Technologies Inc.
|
75.30
|
%
|
Delaware
|
|||
|
BioDefense Corp.
|
100.00
|
%
|
Delaware
|
|||
|
Soligenix BioPharma Canada Incorporated
|
100.00
|
%
|
Canada
|
|||
| Soligenix UK Limited |
100.00
|
% | United Kingdom | |||